Entero Therapeutics, Inc.
ENTO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,153 | -$998 | -$1,260 | -$12,238 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $45 |
| Change in WC | $297 | $604 | $314 | $1,400 |
| Other Non-Cash | $0 | $339 | $127 | $10,622 |
| Operating Cash Flow | -$856 | -$55 | -$819 | -$172 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $336 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $336 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $700 | -$32 |
| Stock Issued | $3,025 | $0 | $0 | $1,730 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$91 | -$163 | $0 | $0 |
| Other Fin. Act. | $91 | $163 | $0 | -$1,730 |
| Financing Cash Flow | $3,025 | $0 | $700 | -$32 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2,506 | -$55 | -$119 | -$203 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11 | $66 | $185 | $388 |
| End Cash | $2,517 | $11 | $66 | $185 |
| Free Cash Flow | -$856 | -$55 | -$819 | -$172 |